RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2009;20:315-319
doi:10.1258/ijsa.2008.008410
© 2009 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahto, M
Right arrow Articles by Mallinson, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

Diagnosis, management and prevalence estimation of gonorrhoea: influences of Aptima Combo 2 assay with alternative target confirmation

M Mahto MRCOG DipGUM/Ven * , S Zia PhD *, D Ritchie RGN BSc {dagger} and H Mallinson PhD {ddagger}

* Genitourinary Medicine Department, Cheshire East Community Health (Central and Eastern Cheshire PCT), Assura Health and Wellness Centre, Watersgreen, Sunderland Street, Macclesfield SK11 6JL, UK; {dagger} Team Chlamydia Office (National Chlamydia Screening Programme), Cheshire East Community Health, Congleton War Memorial Hospital, Congleton CW12 3AR, UK; {ddagger} Clinical Microbiology and Health Protection Agency Collaborating Laboratory, Aintree Hospital NHS Foundation Trust, Liverpool L9 7AL, UK

Correspondence to: Dr M Mahto, Genitourinary Medicine Department, Assura Health and Wellness Centre, Watersgreen, Sunderland Street, Macclesfield SK11 6JL, UK Email: mrinalini.mahto{at}echeshire-tr.nwest.nhs.uk

Case-notes and laboratory data were retrospectively reviewed for influences of dual testing by Aptima Combo 2 (AC2) for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) on the diagnosis, management and prevalence estimation of gonorrhoea in the genitourinary (GU) medicine clinic and community. NG positives by AC2 were confirmed by Aptima Gonococcus assay. Unconfirmed positives were rare. Our study showed that in the GU medicine clinic, AC2 detected about 20% extra cases of NG beyond culture. For best standard of care, NG culture and microscopy are still required in some patients to ensure that treatment is rapid and appropriate. Compared to self-referral at the GU medicine clinic, community tests made a substantial contribution to the overall number of NG cases found (40 community versus 35 Macclesfield GU medicine clinic). The ratio of female to male NG cases found was significantly higher (P = 0.002) in the community (13 M, 27 F) than at the GU medicine clinic (25 M, 10 F). In the community, over 60% of NG infections occurred in chlamydia-negative patients. The overall prevalence of NG in the GU medicine clinic was 1.3%, the true prevalence being much lower at 0.9% on primary test. Prevalence in the community was 0.4%. Data from dual testing in the community can clarify NG prevalence beyond the existing KC60 (sexually transmitted infections) reports.

Key Words: Aptima Combo 2 • nucleic acid amplification tests • confirmation • dual testing • gonorrhoea • culture • management • prevalence


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor